Medilabo RFP

Manufacturing · Japan · 1-10 Employees

View Company Info for Free

Overview

Headquarters

Umetada-cho Sanjo Chohju 24 bldg 4f, Kyo...

Revenue

$5.6 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About Medilabo RFP

Medilabo RFP, Inc. is a clinical-stage biopharmaceutical company based in Japan, with a US office in Boston, specializing in the development of repurposed small molecules aimed at restoring neuronal function and slowing neurodegeneration. The company focuses on innovative treatments for neurological diseases such as Alzheimer's, Parkinson's disease, and Frontotemporal Dementia, utilizing a novel intranasal drug delivery system. Medilabo is advancing its lead candidates, ML1707 and ML1808, which target cognitive impairment through unique mechanisms of action. Their intended clients include patients suffering from various neurodegenerative conditions, as well as healthcare providers seeking effective treatment options.Explore more
Medilabo RFP's Social MediaPopular SearchesMedilabo RFP IncMedilaborfpSIC Code 28,283NAICS Code 32,325Show more

Medilabo RFP Org Chart

TK
Japan flag for contact location.

Chief Executive Officer

PhoneEmail

Is Medilabo RFP your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Medilabo RFP is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Medilabo RFP is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Medilabo RFP.

Medilabo RFP Tech Stack

A closer look at the technologies used by Medilabo RFP

Top Manufacturing Companies

Frequently Asked Questions Regarding Medilabo RFP

What is Medilabo RFP's official website?
Medilabo RFP's official website is www.medilaborfp.com
What is Medilabo RFP's Revenue?
Medilabo RFP's revenue is $5.6 Million
What is Medilabo RFP's SIC code?
Medilabo RFP's SIC: 28,283
What is Medilabo RFP's NAICS code?
Medilabo RFP's NAICS: 32,325
How many employees does Medilabo RFP have?
Medilabo RFP has 1-10 employees
What industry does Medilabo RFP belong to?
Medilabo RFP is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What technology does Medilabo RFP use?
Some of the popular technologies that Medilabo RFP uses are: WordPress.org, PHP, jQuery
What does Medilabo RFP do?

Medilabo RFP, Inc. is a clinical-stage biopharmaceutical company based in Japan, with a US office in Boston, specializing in the development of repurposed small molecules aimed at restoring neuronal function and slowing neurodegeneration. The company focuses on innovative treatments for neurological diseases such as Alzheimer's, Parkinson's disease... , and Frontotemporal Dementia, utilizing a novel intranasal drug delivery system. Medilabo is advancing its lead candidates, ML1707 and ML1808, which target cognitive impairment through unique mechanisms of action. Their intended clients include patients suffering from various neurodegenerative conditions, as well as healthcare providers seeking effective treatment options.Read More

What are Medilabo RFP social media links?
Medilabo RFP Linkedin page
Is Medilabo RFP a public company?
Medilabo RFP is private company therefore does not currently have an official ticker symbol
See more information about Medilabo RFP

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.